|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 194.90 USD | -1.23% |
|
+6.99% | -23.70% |
| 09/04 | Humana Goes Live with b.Well to Deliver on Health Data Interoperability Commitments | CI |
| 08/04 | Evercore ISI Adjusts Price Target on Humana to $195 From $180, Maintains In Line Rating | MT |
Company Valuation: Humana Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 59,622 | 64,843 | 56,361 | 30,550 | 30,806 | 23,689 | - | - |
| Change | - | 8.76% | -13.08% | -45.8% | 0.84% | -23.1% | - | - |
| Enterprise Value (EV) 1 | 68,722 | 70,908 | 63,323 | 40,050 | 38,975 | 34,202 | 33,948 | 33,252 |
| Change | - | 3.18% | -10.7% | -36.75% | -2.68% | -12.25% | -0.74% | -2.05% |
| P/E ratio | 20.5x | 23.2x | 22.9x | 25.4x | 26x | 22.3x | 13.2x | 7.75x |
| PBR | 3.73x | 4.18x | 3.44x | 1.87x | 1.75x | 1.32x | 1.25x | 1.13x |
| PEG | - | -8.91x | -2.43x | -0.5x | -18.53x | -2.2x | 0.2x | 0.1x |
| Capitalization / Revenue | 0.72x | 0.7x | 0.53x | 0.26x | 0.24x | 0.15x | 0.14x | 0.13x |
| EV / Revenue | 0.83x | 0.76x | 0.6x | 0.34x | 0.3x | 0.21x | 0.2x | 0.18x |
| EV / EBITDA | 16.1x | 13.8x | 11.1x | 9.97x | 9.45x | 12.6x | 9.35x | 6.77x |
| EV / EBIT | 27.6x | 16.1x | 12.7x | 11.3x | 14.4x | 16.3x | 11.4x | 7.38x |
| EV / FCF | 72.6x | 20.5x | 21.3x | 16.8x | 104x | 13.2x | 13.2x | 9.79x |
| FCF Yield | 1.38% | 4.89% | 4.7% | 5.97% | 0.96% | 7.57% | 7.6% | 10.2% |
| Dividend per Share 2 | 2.725 | 3.15 | 3.54 | 3.54 | - | 3.898 | 4.111 | 4.07 |
| Rate of return | 0.59% | 0.62% | 0.77% | 1.4% | - | 1.98% | 2.08% | 2.06% |
| EPS 2 | 22.67 | 22.08 | 20 | 9.98 | 9.84 | 8.843 | 14.95 | 25.45 |
| Distribution rate | 12% | 14.3% | 17.7% | 35.5% | - | 44.1% | 27.5% | 16% |
| Net sales 1 | 83,064 | 92,870 | 1,06,374 | 1,17,761 | 1,29,664 | 1,61,386 | 1,71,240 | 1,84,241 |
| EBITDA 1 | 4,278 | 5,122 | 5,711 | 4,016 | 4,124 | 2,724 | 3,630 | 4,911 |
| EBIT 1 | 2,488 | 4,413 | 4,999 | 3,543 | 2,704 | 2,096 | 2,968 | 4,505 |
| Net income 1 | 2,933 | 2,806 | 2,489 | 1,207 | 1,188 | 1,064 | 1,808 | 3,104 |
| Net Debt 1 | 9,100 | 6,065 | 6,962 | 9,500 | 8,169 | 10,513 | 10,259 | 9,562 |
| Reference price 2 | 463.86 | 512.19 | 457.81 | 253.71 | 256.13 | 197.32 | 197.32 | 197.32 |
| Nbr of stocks (in thousands) | 1,28,534 | 1,26,600 | 1,23,111 | 1,20,411 | 1,20,273 | 1,20,054 | - | - |
| Announcement Date | 02/02/22 | 01/02/23 | 25/01/24 | 11/02/25 | 11/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 22.31x | 0.21x | 12.56x | 1.98% | 2.37TCr | ||
| 18.27x | 0.73x | 11.69x | 2.87% | 28TCr | ||
| 11.48x | 0.33x | 7.21x | 2.23% | 7.34TCr | ||
| 13.23x | 0.47x | 9.15x | 2.23% | 6.96TCr | ||
| 19.44x | 0.09x | 9.16x | -.--% | 1.85TCr | ||
| 44.46x | 0.15x | 10.15x | -.--% | 755.58Cr | ||
| 163.07x | 0.77x | 26.56x | -.--% | 436.79Cr | ||
| 14.14x | 0.82x | 4.84x | -.--% | 129.48Cr | ||
| -266.76x | 0.3x | 15.22x | -.--% | 100.21Cr | ||
| 47.8x | 2.68x | 14.15x | 0.58% | 29Cr | ||
| Average | 8.74x | 0.66x | 12.07x | 0.99% | 4.78TCr | |
| Weighted average by Cap. | 17.89x | 0.57x | 10.68x | 2.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- HUM Stock
- Valuation Humana Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















